• 한국유기농업학회지
• /
• 제10권4호
• /
• pp.47-60
• /
• 2002

생균제는 항생제와 반대의 어원적 의미를 갖는 것으로 장내 미생물 균형을 기선함으로써 숙주 동물에게 유익한 작용을 유도할 수 있는 살아있는 미생물 첨가제로서 항생제를 대체할 수 있는 물질 중 하나로서 인식되어 왔다. Lactobacillus와 같은 젖산균은 유산을 생성하여 장의 산도를 pH를 저하시켜 잡균의 오염을 방지하며, 각종 비타민, 아미나산, 항균물질 등을 생산하여 가축 장내 미생물균총의 안정, 사료효율 증가, 내병성 증대 등의 효과가 있다. 또한, saccharomyces와 같은 효모균은 각종 소화효소를 생산하여 영양소 분해를 촉진하며 알코올과 글루타민산과 같은 사료의 기호성을 증진시키는 물질을 분비한다. 단위가축에 있어 생균제의 급여효과는 돼지에 있어 증체량과 사료효율을 증가시키고 설사발생빈도를 낮춘다. 또한, 가금에 있어서는 산란계의 산란율을 개선하고, 장내 유익한 미생물의 수를 증가시키며, 육계의 증체량을 증가시키며, 혈중 콜레스테롤 수치를 낮춘다. 그러나 다른 연구에서는 생균제의 급여가 가축의 성적에 별다른 영향을 미치지 못하였다고 보고하여 이를 규명할 수 있는 연구의 진행이 이루어져야 할 것으로 보인다. 또한, 생균제의 효율적인 이용, 균주의 선발과 광합성미생물과 같은 친환경적인 생균제의 개발등도 해결되어야 할 과제일 것이다.

• Journal of Microbiology and Biotechnology
• /
• 제29권2호
• /
• pp.200-208
• /
• 2019

Probiotics show low cell viability after oral administration because they have difficulty surviving in the stomach due to low pH and enzymes. For the oral delivery of probiotics, developing a formula that protects the probiotic bacteria from gastric acidity while providing living cells is mandatory. In this study, we developed tablets using a new pH-sensitive phthalyl inulin (PI) to protect probiotics from gastric conditions and investigated the effects of different compression forces on cell survival. We made three different tablets under different compression forces and measured survivability, disintegration time, and kinetics in simulated gastric-intestinal fluid. During tableting, there were no significant differences in probiotic viability among the different compression forces although disintegration time was affected by the compression force. A higher compression force resulted in higher viability in simulated gastric fluid. The swelling degree of the PI tablets in simulated intestinal fluid was higher than that of the tablets in simulated gastric fluid due to the pH sensitivity of the PI. The probiotic viability formulated in the tablets was also higher in acidic gastric conditions than that for probiotics in solution. Rapid release of the probiotics from the tablet occurred in the simulated intestinal fluid due to the pH sensitivity. After 6 months of refrigeration, the viability of the PI probiotics was kept. Overall, this is the first study to show the pH-sensitive properties of PI and one that may be useful for oral delivery of the probiotics.

• Journal of Microbiology and Biotechnology
• /
• 제32권5호
• /
• pp.638-644
• /
• 2022

Probiotics modulate the gut microbiota, which in turn regulate immune responses to maintain balanced immune homeostasis in the host. However, it is unclear how probiotic bacteria regulate immune responses. In this study we investigated the immunomodulatory effects of heat-killed probiotics, including Lactiplantibacillus plantarum KC3 (LP3), Lactiplantibacillus plantarum CKDB008 (LP8), and Limosilactobacillus fermentum SRK414 (LF4), via phagocytosis, nitric oxide (NO), and pro-inflammatory cytokine production in macrophages. We thus found that heat-killed LP8 could promote the clearance of foreign pathogens by enhancing the phagocytosis of macrophages. Treatment with heat-killed LP8 induced the production of NO and pro-inflammatory cytokines, including TNF-α, IL-6, and IL-1β. In addition, heat-killed LP8 suppressed the production of NO and cytokines in LPS-induced RAW264.7 cells, suggesting that heat-killed LP8 exerts immunomodulatory effects depending on the host condition. In sum, these results indicate that heat-killed LP8 possesses the potential for immune modulation while providing a molecular basis for the development of functional probiotics prepared from inactivated bacterial cells.

• 한국식품저장유통학회지
• /
• 제30권3호
• /
• pp.538-545
• /
• 2023

본 연구는 probiotics mixture(Lactobacillus acidophilus PBS066(DSM 24936), Lactiplantibacillus plantarum PBS067(DSM 24937), Limosilactobacillus reuteri PBS072(DSM 25175))의 안전성 및 탄수화물 소화 효소 저해 효과를 in vitro로 평가하는 것을 목적으로 한다. 모든 균주는 유럽식품안전처(EFSA) 지침에서 권장하는 항생제 내성 프로필을 충족시켰으며, 모든 균주는 용혈 활성 및 세포 독성을 나타내지 않았다. Probiotics mixture, L. plantarum PBS067 그리고 L. reuteri PBS072는 α-amylase 활성을 억제하는 것으로 나타났으며, probiotics mixture와 이의 균주 3종 모두 α-glucosidase 활성을 억제하는 것으로 나타났다. 이로써 본 연구에 사용한 probiotics mixture 및 이의 단일 균주 3종의 안전성과 탄수화물 소화 억제 효과를 확인하였으며, 따라서 probiotics mixture 이의 단일 균주 3종은 섭취하여도 안전하며 섭취 시 체내 탄수화물 대사를 잠재적으로 조절하는 것을 확인하였다.

• 대한암한의학회지
• /
• 제10권1호
• /
• pp.75-86
• /
• 2005

Disease associated with microorganisms are far from resolved by current therapeutics. One of effective approach to health maintenance and disease control is the use of dietary bacterial and carbohydrate supplements. This comprises use of probiotics and prebiotics. Probiotics mean the live microorganisms, which when administered in adequate amounts confer a health benefit on the host. Prebiotics mean a nondigestible food ingredient that beneficially affects the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria that can Improve the host health. Especially, probiotics has the relation which is close with innate immunity and adaptive immunity. And probiotics has the clinical value with many disease like lactose intolerance, constipation, acute gastroenteritis, food hypersensitivity and allergy, atopic dermatitis, crohn's disease, rheumatoid arthritis, pelvic radiotherapy, intestinal inflammation and chemical exposure, colon cancer, inhibitory effect of Helicobacter pylori and lowering the level of cholesterol. We use jointly korean medicine and probiotics and it has the more therapeutic effect in the many disease.

• Journal of Dairy Science and Biotechnology
• /
• 제39권2호
• /
• pp.63-67
• /
• 2021

Antibiotics are widely used to improve productivity in the dairy industry. However, the inappropriate use of antibiotics causes the deterioration in the quality of dairy products undergoing fermentation and maturation. Hence, probiotic use is emerging as an alternative to curb the increased utilization of antibiotics. Probiotics are defined as "living microorganisms that, when administered in appropriate amounts, confer health benefits on the host." They may improve host disease resistance by regulating intestinal microflora balance and promote animal growth and development. In the dairy industry, probiotics have been studied to increase milk production by improving digestion in dairy cows, enhance the content of dairy components such as milk fat and protein, reduce the risk of mastitis in cows, and increase calf weight. Thus, the use of probiotics can improve the production and safety of dairy products. However, some probiotics are still unstable during storage and have low quality and safety issues. Therefore, to reduce the use of antibiotics in the dairy industry, probiotics should be developed and produced considering the above-mentioned problems.

• Journal of Microbiology and Biotechnology
• /
• 제29권9호
• /
• pp.1335-1340
• /
• 2019

Probiotics, including bacteria and yeast, are live microorganisms that have demonstrated beneficial effects on human health. Recently, probiotic bacteria are constantly being studied and their applications are also being considered in promising adjuvant treatments for various intestinal diseases. Clinical trials and in vivo experiments have extended our current understanding of the important roles that probiotics play in human gut microbiomeassociated diseases. It has been documented through many clinical trials that probiotics could shape the intestinal microbiota leading to potential control of multiple bowel diseases and promotion of overall wellness. In this review, we focused on the relationship between probiotics and the human gut microbiota and its roles in gut microbiome-associated diseases. Here, we also discuss future directions and research areas that need further elucidation in order to better understand the roles of probiotics in the treatment of intestinal diseases.

• Animal Bioscience
• /
• 제35권8호
• /
• pp.1109-1120
• /
• 2022

Antibiotics used to be supplemented to animal feeds as growth promoter and as an effective strategy to reduce the burden of pathogenic bacteria present in the gastro-intestinal tract. However, in-feed antibiotics also kill bacteria that may be beneficial to the animal. Secondly, unrestricted use of antibiotics enhanced the antibiotic resistance in pathogenic bacteria. To overcome above problems, scientists are taking a great deal of measures to develop alternatives of antibiotics. There is convincing evidence that probiotics could replace in-feed antibiotics in poultry production. Because they have beneficial effects on growth performance, meat quality, bone health and eggshell quality in poultry. Better immune responses, healthier intestinal microflora and morphology which help the birds to resist against disease attack were also identified with the supplementation of probiotics. Probiotics establish cross-feeding between different bacterial strains of gut ecosystem and reduce the blood cholesterol level via bile salt hydrolase activity. The action mode of probiotics was also updated according to recently published literatures, i.e antimicrobial substances generation or toxin reduction. This comprehensive review of probiotics is aimed to highlight the beneficial effects of probiotics as a potential alternative strategy to replace the antibiotics in poultry.

• 한국미생물·생명공학회지
• /
• 제50권4호
• /
• pp.465-476
• /
• 2022

The importance of beneficial microorganisms, particularly probiotics, that coexist in the human body, is being increasingly recognized. Probiotics are representative health functional foods that provide health benefits to humans through the production of various metabolites, including short-chain fatty acids. However, the health benefits are strain-specific, and the use of each probiotic strain should follow guidelines that assure its safety. Accurate identification of the strain should be managed through genetic and phenotypic analyses of the strain. Besides, the functionality of probiotics should be disclosed in vitro and in vivo so that they can be used as legal functional ingredients (i.e., individual standards). In this review, we deal with the guidelines, including the technical factors related to probiotic strains. The common health effects of probiotic strains include proliferation of beneficial bacteria, control of harmful bacteria, and facilitation of bowel activities. Probiotics with various functionalities (e.g., body fat and cholesterol reduction, vaginal health, and improvement of skin's immune system) have been investigated as "individual standards of raw materials for health functional foods" provided by MFDS. In the future, various biotechnologies including synthetic biology can be applied to produce customized probiotics to improve human health.

• 한국축산시설환경학회지
• /
• 제12권2호
• /
• pp.67-74
• /
• 2006

본 시험은 L. acidophilus, L. bulgaricu, S. lactis, A. oryzae 등의 유용미생물이 혼합된 생균제와 여기에 Xylanase 1,000,000 unit를 혼합한 복합생균효소제를 비육돈 사료에 각각 0.1% 수준으로 첨가하여 급여하였을 때 비육돈사내 암모니아, 황화수소 및 이산화탄소 농도와 증체량, 사료섭취량, 사료요구율에 미치는 영향을 분석하기 위하여 3처리${\times}$3반복${\times}$13두로써 총 117두를 공시하여 실시하였는데, 그 결과를 요약하면 다음과 같다. 복합생균효소제 급여가 비육돈사내 환경개선에 미치는 영향은 긍정적인 것으로 평가된다. 복합생균효소제 급여는 돈사내 암모니아 농도를 30% 이상 저감시키는 효과가 인정되었으며, 황화수소 농도는 복합생균효소제 0.1% 급여구가 대조구에 비하여 뚜렷한 저감효과를 나타내었다. 그러나 이산화탄소 농도에는 영향을 미치지 않았다. 생균제와 복합생균효소제 급여는 일당증체량에는 영향을 미치지 않았으나, 사료섭취량은 복합생균효소제 0.1% 급여구가 가장 낮았으며(p<0.05), 사료요구율은 복합생균효소제 0.1% 급여구가 가장 우수하게(p<0.05) 나타났다. 그러나 생균제와 복합생균효소제 급여구 간에는 차이가 인정되지 않았다. 이상의 결과를 요약해보면 비육돈에 대한 생균제와 복합생균효소제 급여는 사료요구율을 개선시키고, 돈사내 암모니아 및 황화수소 농도에 영향을 미치며, 암모니아의 경우 30% 이상의 저감효과가 인정된다.